MMA
BBIO icon

Mizuho Markets Americas’s BridgeBio Pharma BBIO Stock Holding History

Mizuho Markets Americas’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Buy
182,408
+11,120
+6% +$779K 0.21% 87
2026
Q1 		$12.7M Buy
171,288
+9,500
+6% +$689K 0.35% 64
2025
Q4 		$12.4M Buy
161,788
+21,416
+15% +$1.41M 0.24% 86
2025
Q3 		$7.29M Buy
140,372
+44,300
+46% +$2.16M 0.14% 83
2025
Q2 		$4.15M Buy
96,072
+1,897
+2% +$69K 0.13% 63
2025
Q1 		$3.26M Buy
94,175
+4,000
+4% +$135K 0.07% 98
2024
Q4 		$2.47M Buy
90,175
+2,995
+3% +$77.4K 0.04% 179
2024
Q3 		$2.22M Buy
87,180
+3,198
+4% +$84K 0.05% 147
2024
Q2 		$2.13M Buy
83,982
+9,673
+13% +$264K 0.05% 163
2024
Q1 		$2.3M Buy
74,309
+9,930
+15% +$338K 0.06% 142
2023
Q4 		$2.6M Sell
64,379
-16,153
-20% -$485K 0.07% 134
2023
Q3 		$2.12M Sell
80,532
-5,916
-7% -$168K 0.07% 140
2023
Q2 		$1.49M Sell
86,448
-7,750
-8% -$117K 0.1% 30
2023
Q1 		$1.56M Buy
94,198
+4,600
+5% +$53.6K 0.06% 62
2022
Q4 		$683K Buy
89,598
+5,000
+6% +$47.9K 0.04% 112
2022
Q3 		$841K Hold
84,598
– – 0.04% 109
2022
Q2 		$768K Sell
84,598
-7,600
-8% -$63.6K 0.06% 69
2022
Q1 		$936K Sell
92,198
-42,300
-31% -$434K 0.06% 56
2021
Q4 		$2.24M Sell
134,498
-48,230
-26% -$2.04M 0.12% 41
2021
Q3 		$8.56M Sell
182,728
-10,998
-6% -$590K 0.68% 22
2021
Q2 		$11.8M Buy
193,726
+21,803
+13% +$1.25M 1.39% 14
2021
Q1 		$10.6M Buy
+171,923
New +$11.2M 4.93% 8

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Mizuho Markets Americas's BBIO Position: Q2 2026 in Review

Mizuho Markets Americas increased its BridgeBio Pharma (BBIO) stake by 6.5% in Q2 2026, buying an estimated $779K and bringing the position to 182,408 shares worth $13.6M. The position accounts for 0.21% of the portfolio, ranked #87.

Mizuho Markets Americas first reported a position in BBIO in Q1 2021 and has held it in 22 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Mizuho Markets Americas held 182,408 shares of BridgeBio Pharma worth $13.6M as of Q2 2026.
  • Mizuho Markets Americas bought 11,120 BridgeBio Pharma shares in Q2 2026, an estimated $779K.
  • BridgeBio Pharma made up 0.21% of Mizuho Markets Americas's portfolio in Q2 2026, its #87 holding.
  • Mizuho Markets Americas first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 22 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Mizuho Markets Americas's 13F filing for Q2 2026, filed 24 Jul 2026.